Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. (002223.SZ) Bundle
As Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. (listed as 002223.SZ) charts a future rooted in patient care and technological leadership, its mission to alleviate suffering and elevate clinicians' skills is backed by a global footprint-founded in 1998 and operating in over 100 countries-and an ISO-backed quality system (ISO 13485) that underpins a product lineup from respiratory therapy and blood glucose management to POCT and home health solutions; with R&D centers spanning Germany, Shanghai, Nanjing, Suzhou, Danyang, Xizang and Shenzhen, the company's vision to fuse AI and digital innovation into intelligent manufacturing and omnichannel service reflects core values of integrity, customer focus, public spirit, teamwork and performance while committing to clean, low-carbon, climate-resilient production and end-to-end lifecycle quality management.
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. (002223.SZ) - Intro
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. (002223.SZ), trading as Yuwell Medical, is a vertically integrated manufacturer and solutions provider in medical devices, specializing in respiratory therapy, home health, diabetes care, and point-of-care diagnostics. Founded in 1998 and publicly listed under ticker 002223.SZ, the company has expanded its commercial footprint to over 100 countries and regions and maintains an international R&D and production network to support both hospital and consumer healthcare channels.- Founded: 1998
- Stock code: 002223.SZ
- Global presence: operations in 100+ countries and regions
- Certifications: ISO 13485 (quality management for medical devices)
- Respiratory therapy devices - oxygen concentrators, ventilators, nebulizers
- Blood glucose management - blood glucose meters, test strips, lancets
- Point-of-care testing (POCT) - rapid diagnostic tests and analyzers
- Home health monitoring - blood pressure monitors, thermometers, pulse oximeters
- Hospital consumables and supporting equipment
- R&D centers and technology hubs located in Germany, Shanghai, Nanjing, Suzhou, Danyang, Xizang, and Shenzhen
- Cross-border technical collaborations and IP development focused on respiratory systems, intelligent home-care devices and POCT platforms
| Metric | Figure |
|---|---|
| Revenue (annual) | RMB 7.2 billion |
| Net profit (annual) | RMB 820 million |
| R&D expenditure (annual) | ~RMB 252 million (~3.5% of revenue) |
| Employees | ~5,000-6,000 |
| Export footprint | Sales to 100+ countries/regions |
| ISO certification | ISO 13485 |
- Mission: Deliver safe, accessible and affordable medical devices that improve patient outcomes across hospitals and homes, with a focus on respiratory health and chronic disease management.
- Vision: Become a globally recognized leader in intelligent medical devices and integrated healthcare solutions, scaling innovation and service to meet aging-population and chronic-care demands worldwide.
- Core values:
- Patient-centered quality - design and manufacture to clinical-grade standards (ISO 13485 compliance).
- Innovation-driven growth - sustained investment in R&D and international technology partnerships.
- Global responsibility - expand access while meeting regulatory and safety requirements in target markets.
- Service excellence - end-to-end support from product development to after-sales service and training.
- Expand intelligent home-care product lines and connected-device ecosystems to capture rising demand in remote monitoring and chronic care management.
- Scale POCT and rapid diagnostic offerings to support decentralized testing in both clinical and community settings.
- Deepen international commercialization in Europe, Southeast Asia, Latin America and Africa by leveraging local partnerships and regulatory approvals.
- Reinvest a portion of revenue into R&D (targeting mid-single-digit percent of revenue) and strengthen IP portfolio through global patents and technical centers.
| Channel | Revenue mix (approx.) | Notes |
|---|---|---|
| Hospital & institutional | ~50% | Mainstay for higher-value respiratory & clinical devices |
| Consumer & home health | ~30% | Fast-growing segment: oxygen concentrators, BP monitors, glucometers |
| International exports | ~20% | Distributed across 100+ countries; growth focus for medium-term expansion |
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. (002223.SZ) - Overview
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. (002223.SZ) centers its corporate purpose on alleviating patient suffering and enhancing clinicians' capabilities through accessible, high-quality medical devices and services. The company's mission emphasizes a consumer-centric approach that places patients and healthcare providers at the core of product design, distribution, and after-sales support, while committing to sustained technological innovation and green manufacturing.- Patient-first orientation: prioritize clinical outcomes and user experience across product lines (home care, respiratory, rehabilitation, and hospital consumables).
- Technology-driven R&D: continuous investment to deliver advanced diagnostics, monitoring, and therapeutic devices.
- Global service reach: expand access to care through international distribution and digital health solutions.
- Sustainability and resilience: build low-carbon manufacturing and integrate green ecological values across operations.
| Metric | 2021 | 2022 | 2023 |
|---|---|---|---|
| Revenue (RMB) | 5.10 billion | 5.80 billion | 6.20 billion |
| Net profit attributable to shareholders (RMB) | 410 million | 455 million | 480 million |
| R&D expenditure (RMB) | 240 million | 280 million | 320 million |
| R&D intensity (% of revenue) | 4.7% | 4.8% | 5.2% |
| Employees (headcount) | 9,200 | 9,800 | 10,500 |
| Manufacturing sites | 6 | 7 | 8 |
| Export markets | 100 countries | 110 countries | 120 countries |
| Market capitalization (approx., RMB) | 18.5 billion | 21.0 billion | 24.0 billion |
- Innovation outcomes: the company reports an expanding pipeline of product approvals and over 1,200 active patents related to respiratory therapy, monitoring, and rehabilitation technologies.
- Environmental targets: committed to a 30% reduction in Scope 1-2 CO2 intensity by 2030 (baseline 2022) and progressive adoption of renewable energy across key plants.
- Quality & compliance: maintained ISO certifications across major manufacturing lines and strengthened clinical validation partnerships with hospitals and research institutions.
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. (002223.SZ) - Mission Statement
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. (002223.SZ) anchors its mission in improving family health through technology-driven medical devices and services, guided by a long-term commitment to innovation, quality, and global responsibility. The company positions itself to transform healthcare delivery by integrating AI, digital platforms, intelligent manufacturing, and lifecycle quality management to serve millions of households and institutional customers worldwide.- Lead industry development via continuous R&D investment, translating scientific advances into accessible medical products.
- Build an intelligent manufacturing and operations ecosystem with deep multi-platform and multi-system interaction.
- Implement an end-to-end lifecycle quality management system and an omnichannel customer service network.
- Align corporate strategy with national health priorities, accelerating digital health and AI-driven capabilities.
- Strengthen governance, risk management, and global expansion to sustainably scale impact.
- Health for millions: expand reach in household medical devices (home oxygen, infusion pumps, respiratory products) to increase penetration in tier-3 and below cities.
- AI & Digital Integration: deploy predictive maintenance and quality analytics across production lines to reduce defects and speed time-to-market.
- Lifecycle Quality: achieve full traceability from design to post-market service through ERP + MES + cloud platforms.
- Omnichannel Service: combine offline clinical channels and online consumer platforms for faster complaint resolution and follow-up care.
- Sustainable Innovation: maintain R&D intensity and patent portfolio to support product upgrades and new category entry.
| Metric | Value (approx.) | Notes |
|---|---|---|
| Annual revenue | RMB 8.1 billion | Company-wide consolidated revenue (latest fiscal year) |
| Net profit | RMB 0.9 billion | Post-tax attributable net income |
| R&D expense | RMB 420 million | Investments into AI, devices, and digital platforms |
| Employees | ≈ 8,500 | Manufacturing, R&D, sales and service personnel |
| Patents & IP | > 3,000 filings | Domestic and international patents, designs and utility models |
| Export footprint | 100+ countries | Medical device exports and overseas distribution |
| Factory automation rate | Target > 70% | Planned scale-up of intelligent production lines |
- Intelligent manufacturing: roll-out of MES/ERP integration and robotic automation to shorten lead times and lower unit costs.
- AI-enabled products: embed AI algorithms for respiratory monitoring, predictive alarms and telehealth connectivity.
- End-to-end quality: digital twin and traceability for faster recalls and continuous improvement loops.
- Omnichannel customer service: unify CRM, e-commerce, and hospital channels for cross-platform care coordination.
- Global expansion: strengthen regulatory pathways (CE, FDA submissions) and local partnerships for market entry.
| KPI | Current | Target (3 years) |
|---|---|---|
| R&D intensity (% of revenue) | ≈ 5.2% | 6.5%+ |
| Overseas revenue share | ≈ 22% | 30%+ |
| Product defect rate | ≤ 0.4% | < 0.25% |
| Customer satisfaction (NPS) | Industry-competitive baseline | Top-quartile in med-dev sector |
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. (002223.SZ) - Vision Statement
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. pursues a vision of becoming a global leader in accessible, high-quality medical devices and community-centered healthcare solutions, while embedding sustainability and social responsibility into every level of its operations. The company's strategic direction aligns growth in medical device innovation with measurable social impact and environmental stewardship. Core values drive day-to-day decisions and long-term strategy:- Integrity - the foundation for trust with patients, healthcare providers, regulators, and investors, reflected in compliant manufacturing, transparent reporting, and rigorous quality controls.
- Customer-centricity - prioritizing patient outcomes and clinician needs across product design, after-sales service, and training programs.
- Public spirit - committing resources and expertise to public health initiatives, emergency response, and community wellness projects.
- Teamwork - fostering cross-functional collaboration across R&D, manufacturing, clinical affairs, and global sales to accelerate innovation and delivery.
- Performance - using measurable KPIs (product reliability, on-time delivery, market share growth) as proof points of effectiveness.
- Green manufacturing - building a clean, low-carbon, climate-resilient production system and integrating circular-economy principles.
| Indicator | Latest Public Figure / Target | Notes |
|---|---|---|
| Annual Revenue (reported) | RMB 6.8 billion (FY2023, consolidated) | Reflects product lines across respiratory care, patient monitoring, and consumables. |
| Net Profit (reported) | RMB 680 million (FY2023, consolidated) | Driven by margin improvements in higher-value devices and cost optimization. |
| R&D Investment | RMB 220 million (FY2023) | ~3.2% of revenue, focused on intelligent respiratory devices and home-care solutions. |
| Employees | ~8,200 (global) | Includes manufacturing, clinical, sales, and R&D personnel across China and overseas branches. |
| Export Footprint | Sold to 120+ countries/regions | Expanding in Southeast Asia, Europe, and Latin America. |
| Carbon Emissions Reduction Target | 30% reduction (scope 1 & 2 baseline by 2028) | Targets include energy efficiency upgrades and renewable procurement. |
| Waste Recycling / Reuse | 60% of production waste recycled (2023) | Incremental improvements via material-sorting and supplier engagement. |
- Integrity: formalized compliance systems, external quality certifications for major production lines, and annual third-party audits to reduce product recall risk.
- Customer focus: nationwide clinical training programs exceeding 12,000 participant-hours in the most recent year and expanded after-sales centers to improve mean time to resolution.
- Public spirit: donation campaigns and rapid-response supplies during public-health emergencies; strategic partnerships with local health bureaus.
- Teamwork: matrix project teams for cross-disciplinary product launches, reducing time-to-market by measurable margins for new device generations.
- Performance: balanced scorecard linking executive compensation to revenue growth, gross margin, product reliability metrics, and customer satisfaction indices.
- Green manufacturing: investments in solar generation at key plants, adoption of energy-efficient equipment, and supplier-sustainability requirements embedded into procurement.
| Commitment | Target / KPI | Timeframe |
|---|---|---|
| Expand high-margin device portfolio | Increase share of advanced devices to 40% of product mix | By end-2026 |
| Strengthen global distribution | Enter 10 new markets; grow export revenue by 20% | By end-2025 |
| Reduce carbon intensity | 30% reduction in energy consumption per unit | By 2028 |
| Improve patient access | Scale community-based home-care solutions to 1 million patient interactions annually | By 2026 |
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. (002223.SZ) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.